F. Wang

691 total citations
11 papers, 184 citations indexed

About

F. Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, F. Wang has authored 11 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in F. Wang's work include Colorectal Cancer Treatments and Studies (3 papers), Peptidase Inhibition and Analysis (2 papers) and Magnesium Alloys: Properties and Applications (2 papers). F. Wang is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Peptidase Inhibition and Analysis (2 papers) and Magnesium Alloys: Properties and Applications (2 papers). F. Wang collaborates with scholars based in China, United States and France. F. Wang's co-authors include Naigen Zhou, Xiaowu Hu, Jiangwen Liao, Xiao‐Jiang Chen, Xia Lin, Guifang Guo, Chang Jiang, Chenxi Yin, Wenjing Zeng and Lin Liu and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Applied Surface Science.

In The Last Decade

F. Wang

9 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Wang China	6	97	84	61	36	31	11	184
Rafał Walczak Poland	10	20 0.2×	36 0.4×	35 0.6×	20 0.6×	20 0.6×	31	373
Ryota Okamoto Japan	7	23 0.2×	46 0.5×	16 0.3×	5 0.1×	22 0.7×	12	293
Jiaxu Wang China	10	39 0.4×	90 1.1×	43 0.7×	10 0.3×	17 0.5×	25	282
Xing Ran China	8	74 0.8×	69 0.8×	5 0.1×	12 0.3×	11 0.4×	33	205
Hong-Jie Pang China	11	64 0.7×	227 2.7×	48 0.8×	20 0.6×	4 0.1×	17	340
Jie Lv China	9	27 0.3×	88 1.0×	17 0.3×	3 0.1×	18 0.6×	21	241
Qingyong Liu China	11	117 1.2×	28 0.3×	2 0.0×	17 0.5×	28 0.9×	34	336
Dongxin Yang China	9	31 0.3×	120 1.4×	20 0.3×	8 0.2×	4 0.1×	18	310
Divya Chandra United States	9	151 1.6×	88 1.0×	31 0.5×	20 0.6×	6 0.2×	18	360

Countries citing papers authored by F. Wang

Since Specialization

Citations

This map shows the geographic impact of F. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Wang more than expected).

Fields of papers citing papers by F. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Wang. The network helps show where F. Wang may publish in the future.

Co-authorship network of co-authors of F. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of F. Wang. A scholar is included among the top collaborators of F. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Wang. F. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Huang, Rui, Na An, Jiajia Hu, et al.. (2024). Pan-cancer analysis of heterogeneity of tumor mutational burden and genomic mutation under treatment pressure. ESMO Open. 9(7). 103494–103494. 3 indexed citations

Jin, Ying, Ting Hou, Yang Chen, et al.. (2022). P-170 Exploratory biomarker findings from regorafenib plus toripalimab in patients with refractory metastatic colorectal cancer (REGOTORI study). Annals of Oncology. 33. S310–S310. 2 indexed citations

Zhao, Hu, Xiaoli Wei, Yuqing Huang, et al.. (2021). 1329P A single-arm, open-label, multi-center, phase I study of HA121-28 in patients with advanced solid tumors. Annals of Oncology. 32. S1018–S1018. 3 indexed citations

Liu, Xiuli, F. Wang, Xue Hou, et al.. (2021). P35.01 Genomic Origin and Immune-related Status of Pulmonary Sarcomatoid Carcinoma. Journal of Thoracic Oncology. 16(3). S419–S419.

Wang, F., Zhongqing Wang, Ying Jin, et al.. (2020). 433P A phase Ib/II clinical trial of tolerability, safety and efficacy of regorafenib in combination with toripalimab (a PD-1 antibody) in patients with relapsed or metastatic colorectal cancer. Annals of Oncology. 31. S425–S425. 6 indexed citations

Liu, Lin, et al.. (2014). Pretreatment of Transfused Donor Splenocytes and Allografts With Mitomycin C Attenuates Acute Rejection in Heart Transplantation in Mice. Transplantation Proceedings. 46(4). 1169–1174. 7 indexed citations

Liao, Jiangwen, et al.. (2014). Properties of Mg2Si (100) surfaces: A first-principles study. Solid State Communications. 183. 41–46. 18 indexed citations

Wang, F., et al.. (2013). First-principles calculations on Mg/Al4C3 interfaces. Applied Surface Science. 270. 584–589. 86 indexed citations

Guo, Guifang, Chenxi Yin, Chang Jiang, et al.. (2013). Gamma‐glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer. Colorectal Disease. 15(8). e443–52. 34 indexed citations

10.

Wang, F., et al.. (2013). First-principles calculations on Mg/Al2CO interfaces. Applied Surface Science. 285. 879–884. 25 indexed citations

11.

Xu, Rui‐Hua, Yanxia Shi, Jianping Xiong, et al.. (2007). Phase II clinical trial of XELOX as first line treatment for patients with unresectable or metastatic gastric cancer. Journal of Clinical Oncology. 25(18_suppl). 15062–15062.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact